Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serpin family A member 10 is a plasma glycoprotein serine protease inhibitor primarily expressed in the liver and secreted into the blood. Its canonical role is to inhibit coagulation factors Xa and XIa—key enzymes in the coagulation cascade—thereby regulating blood clot formation in a protein Z-, calcium-, and phospholipid-dependent manner. Deficiencies or genetic variants of SERPINA10 are associated with thrombotic disease. SERPINA10, like other serpins, is critically involved in maintaining the balance between coagulation and anticoagulation. While it is considered a potential target for modulation in disorders of hemostasis, no direct inhibitors or activators are currently approved for clinical use.
Inhibition of coagulation factors Xa and XIa, decreasing generation of thrombin and opposing pro-thrombotic states
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin family A member 10 (SERPINA10).